Anhui Jimin Cancer Hospital is a tertiary non-profit cancer hospital approved by the Anhui Provincial Health Board, and it is recommended as the national key cancer hospital. It is a designated hospital for provincial and city health insurance and the new rural cooperative medical insurance. After more than 10 years of development, it has developed into the largest joint-stock cancer hospital in China. Located in Xinhai Road, Xinzhan Development Zone, Hefei City, the hospital covers an area of 50 mu. The investment in the first phase is 500 million yuan with 700 beds. In 2011, it cooperated with a listed company Shanghai Fosun Pharma Group. Anhui Jimin International Health Industry Park project with a total investment of 2 billion yuan has been included in the planning.
The hospital adheres to the “people-oriented” service principle and the hospital governing spirit of “dedication, being ready to get along with patients, being realistic and seeking the best.” With “developing hospital with science and technology as the core, and brand development as direction,” the hospital insists on taking development model of “large specialized department, and small comprehensive department” and strives to create a large, modern, brand specialized tumor hospital with good medical technical skills, excellent service, elegant environment and advanced equipment. In the past more than 10 years, the hospital received a total of more than 100,000 patients, creating good social benefits and creating a good reputation and brand image among common people gradually. It has won honorary titles such as the “Advanced National Private Non-Enterprise Unit in Self-Discipline and Integrity Construction”, “Top Ten Influential Brand in Medical and Health Industry in Anhui Province”, “Best Brand Unit in Anhui Province”, “Honest Hospital in Anhui Province”, “100 Excellent Social Organizations in Anhui Province”, “Top Ten Brand Credit Units in Anhui Province”, “Private Non-Enterprise 5A Unit in Anhui Province” and “100 Hospitals of Good Reputations in China”.